UnitedHealth (UNH)care announced more than half of its prior authorization volume will be included in an industrywide effort to standardize submission requirements for electronic prior authorization, and that number will advance to more than 70% by the end of 2026. This step is the next phase of the company’s ongoing efforts to modernize and simplify prior authorization for care providers and help patients more easily and quickly access safe, high-quality, evidence-based care, all while preserving important clinical safeguards. This new UnitedHealthcare initiative reflects growing industry alignment around a standardized approach to electronic prior authorization submissions, shaped in large part by UnitedHealthcare’s partnership and leadership with fellow health plans. The new standardized documentation process will apply across UnitedHealthcare’s commercial, Medicare Advantage and Medicaid offerings. The company will be working aggressively to add more services, as well as further reduce prior authorization requirements and volumes over the next several months. “Today’s announcement is another step in our work to modernize health care, making prior authorization quicker, simpler and more efficient,” said Tim Noel, CEO, UnitedHealthcare. “These changes help care providers and patients save time and money and set the stage for a more seamless electronic experience, and our work will continue as we pursue a modern, touchless authorization process.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- UnitedHealth Stock Forecast: Trending Mixed Signals From Analysts
- UnitedHealth price target raised to $337 from $311 at TD Cowen
- UnitedHealth: Solid Earnings and Raised Guidance Offset by Cost Pressures, Supporting a Hold Rating
- Mixed options sentiment in UnitedHealth with shares up 2.28%
- UnitedHealth price target raised to $370 from $330 at Raymond James
